OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Alleyn Plowright

1 Projects | 1 Researchers | $2,508,003 Invested

2024

Pangea Botanica Ltd

Alleyn Plowright, BSc, PhD

AD back on track: CMC and preclinical development activities to support Phase 1 regulatory filing of OT-003, a novel small molecule TrkB receptor modulator with disease-modifying potential

  • Funding Amount: $2,508,003
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed